IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,966,168 | -4.9% | 134,464 | +2.3% | 0.00% | – |
| Q2 2023 | $6,276,091 | +28.3% | 131,464 | +5.8% | 0.00% | – |
| Q1 2023 | $4,890,457 | -28.8% | 124,281 | -48.8% | 0.00% | – |
| Q4 2022 | $6,869,434 | +89.0% | 242,822 | +100.9% | 0.00% | – |
| Q3 2022 | $3,634,000 | -10.8% | 120,890 | +0.7% | 0.00% | – |
| Q2 2022 | $4,076,000 | -19.9% | 120,091 | +5.9% | 0.00% | – |
| Q1 2022 | $5,087,000 | +7.4% | 113,452 | +10.7% | 0.00% | – |
| Q4 2021 | $4,737,000 | +41.7% | 102,502 | +3.0% | 0.00% | – |
| Q3 2021 | $3,342,000 | +17.8% | 99,488 | +3.2% | 0.00% | – |
| Q2 2021 | $2,836,000 | +20.3% | 96,438 | +5.5% | 0.00% | – |
| Q1 2021 | $2,357,000 | +10.7% | 91,445 | -2.1% | 0.00% | – |
| Q4 2020 | $2,129,000 | +14.8% | 93,394 | +7.6% | 0.00% | – |
| Q3 2020 | $1,855,000 | +9.8% | 86,758 | +19.2% | 0.00% | – |
| Q2 2020 | $1,689,000 | +19.5% | 72,782 | +9.9% | 0.00% | – |
| Q1 2020 | $1,413,000 | -6.9% | 66,196 | +2.0% | 0.00% | – |
| Q4 2019 | $1,517,000 | +25.5% | 64,895 | +12.8% | 0.00% | – |
| Q3 2019 | $1,209,000 | +6.7% | 57,538 | +3.9% | 0.00% | – |
| Q2 2019 | $1,133,000 | -26.2% | 55,402 | +1.3% | 0.00% | – |
| Q1 2019 | $1,536,000 | +4.5% | 54,682 | -9.0% | 0.00% | – |
| Q4 2018 | $1,470,000 | -30.6% | 60,085 | +5.4% | 0.00% | – |
| Q3 2018 | $2,118,000 | +212.9% | 56,987 | +74.7% | 0.00% | – |
| Q2 2018 | $677,000 | +13.8% | 32,618 | -51.3% | 0.00% | – |
| Q1 2017 | $595,000 | +20.9% | 67,001 | +51.2% | 0.00% | – |
| Q4 2016 | $492,000 | -34.1% | 44,301 | +0.7% | 0.00% | – |
| Q3 2016 | $747,000 | -18.5% | 43,975 | +4.5% | 0.00% | – |
| Q2 2016 | $917,000 | +52.1% | 42,082 | +33.7% | 0.00% | – |
| Q1 2016 | $603,000 | -19.0% | 31,473 | +18.4% | 0.00% | – |
| Q4 2015 | $744,000 | +67.2% | 26,573 | +45.1% | 0.00% | – |
| Q3 2015 | $445,000 | +44.5% | 18,313 | +38.4% | 0.00% | – |
| Q2 2015 | $308,000 | – | 13,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |